NCT01402271 2023-12-11Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 1/2 Completed88 enrolled